Goldman Sachs is in a clear intermediate downtrend within a longer-term recovery structure: the stock is up 16.64% over the past year but has fallen 15.62% from its prior close-to-close reference and sits at $875.68, which is only 30.5% of the way up its 52-week range of $754.00 to $1,153.99 (roughly 24% below the high and 16% above the low). That positioning near the lower third of the annual range signals momentum has broken down rather than merely consolidated, and the -23.99% max drawdown confirms a meaningful de-risking has already occurred. The 1-year gain is now largely a legacy of the spring and summer rally, leaving the stock vulnerable to further mean reversion toward the 52-week low unless buyers defend the $850-880 zone.

Short-term momentum is decisively negative and diverging sharply from the trailing 1-year trend: the stock is down 6.48% over one month and 17.48% over three months, versus a 1-year gain of 16.64%, a classic deceleration pattern in which the medium-term trend has rolled over. Relative strength confirms the underperformance — GS has lagged SPY by 5.46 percentage points over one month and a striking 20.33 points over three months, while SPY itself gained 2.85% over that stretch, meaning this is idiosyncratic weakness, not just market beta. The most recent session's -1.75% decline on volume of about 1.78 million shares suggests selling pressure persists into the print, and the absence of a sustained bounce off the October lows argues against calling a bottom yet.

Key technical levels are well defined: support sits at the 52-week low of $754.00, with an intermediate shelf around $875-880 where the stock is currently oscillating, while resistance is anchored at the $1,153.99 high, with secondary resistance near $1,000-1,050 where the September breakdown began. A decisive break below $875 would open the path toward the $800s and ultimately the $754 low, signaling the market is pricing in a cyclical peak in capital markets activity; reclaiming $1,000 would be the first evidence of trend repair. With a beta of 1.284, GS is roughly 28% more volatile than the S&P 500, so position sizing should account for amplified drawdowns — the 23.99% peak-to-trough decline is consistent with that leverage to market moves, and a short ratio of 3.2 days indicates moderate but not extreme bearish positioning.

Revenue momentum is exceptionally strong and accelerating: Q2 2026 revenue reached $38.43 billion, up 22.91% year-over-year from $31.27 billion in Q2 2025, and the quarterly progression shows a powerful upward trajectory — from $30.13 billion in Q4 2025 to $17.23 billion in Q1 2026 (a seasonally lighter quarter) to the $38.43 billion Q2 print, with Q3 2026 results reportedly beating on a 72% surge in equities revenues. Segment data show Global Markets at $20.63 billion and Investment Management at $9.22 billion, confirming that trading and asset management are the twin engines, with the markets franchise driving the bulk of the upside. The 22.91% growth rate, layered on top of a strong 2025 base, implies the capital markets cycle is in an expansion phase, which is the core bull case — but it also raises the cyclicality question of how much of this is sustainable into 2027.

Profitability is robust and expanding: Q2 2026 net income was $6.63 billion on a 17.25% net margin, with gross margin at 52.66% and operating margin at 29.99%, and the trend across quarters is clearly upward — net margin rose from 12.75% in Q4 2025 to 32.68% in Q1 2026 and 17.25% in Q2 2026, while operating margin climbed from 19.44% to 29.99%. The Q1 2026 gross margin of 98.17% reflects a quarter with minimal cost of revenue, so the more comparable Q2 figure of 52.66% is the better read, and it still represents meaningful expansion versus the 45.41% gross margin in Q2 2025. For a capital markets bank, a ~17% net margin and ~30% operating margin are healthy and consistent with a favorable mix of high-margin advisory and trading revenue, though the quarterly volatility in margins underscores the earnings sensitivity to deal and trading volumes.

Balance sheet and cash flow present a mixed but manageable picture typical of an investment bank: debt-to-equity stands at 4.88x, ROE is 13.74%, and ROA is a thin 1.11%, reflecting the leveraged nature of the model, while the current ratio of 0.83 is normal for a firm funding itself largely through wholesale markets. Free cash flow is negative at -$41.52 billion on a trailing basis, driven by a -$32.43 billion FCF quarter in Q1 2026 tied to working capital and investment purchases, though Q2 2026 rebounded to positive $5.60 billion in FCF and $6.11 billion in operating cash flow, and the firm returned capital via $4.0 billion of buybacks and $1.60 billion of dividends in the quarter. The negative PCF ratio of -6.09 and the 4.88x leverage mean the company depends on external financing and market conditions, but a 13.74% ROE and consistent buyback capacity indicate the franchise generates adequate returns on capital when the cycle cooperates.